Breaking News Instant updates and real-time market news.

AIR

AAR Corp.

$46.83

0.18 (0.39%)

, BWXT

BWX Technologies

$63.76

0.3 (0.47%)

04:55
08/29/18
08/29
04:55
08/29/18
04:55

Seaport Global to hold a conference

Global Energy and Industrials Conference will be held in Chicago on August 28-29.

AIR

AAR Corp.

$46.83

0.18 (0.39%)

BWXT

BWX Technologies

$63.76

0.3 (0.47%)

CRZO

Carrizo Oil & Gas

$23.30

-0.57 (-2.39%)

CVGI

Commercial Vehicle Group

$9.99

0.01 (0.10%)

CW

Curtiss-Wright

$134.12

-1 (-0.74%)

FSS

Federal Signal

$26.05

-0.1 (-0.38%)

GDP

Goodrich Petroleum

$13.04

0.245 (1.92%)

HPR

HighPoint Resources

$5.29

0.17 (3.32%)

HSC

Harsco

$27.30

-0.3 (-1.09%)

IEA

Infrastructure and Energy Alternatives

$10.08

-0.08 (-0.79%)

KTOS

Kratos Defense

$13.26

0.2 (1.53%)

LECO

Lincoln Electric

$93.57

-0.34 (-0.36%)

MNTX

Manitex

$10.49

-0.15 (-1.41%)

MRC

MRC Global

$20.22

0.36 (1.81%)

OII

Oceaneering

$28.10

-0.21 (-0.74%)

PDCE

PDC Energy

$55.01

1.24 (2.31%)

REGI

Renewable Energy

$25.75

-0.7 (-2.65%)

SLB

Schlumberger

$64.07

-0.77 (-1.19%)

SLCA

U.S. Silica

$22.34

-0.1 (-0.45%)

TREX

Trex Company

$83.28

1.04 (1.26%)

WERN

Werner

$36.70

-0.45 (-1.21%)

WRD

WildHorse Resource

$20.82

0.04 (0.19%)

  • 29

    Aug

  • 29

    Aug

  • 04

    Sep

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

  • 06

    Sep

  • 06

    Sep

  • 12

    Sep

  • 13

    Sep

  • 13

    Sep

  • 27

    Sep

  • 19

    Oct

  • 06

    Nov

AIR AAR Corp.
$46.83

0.18 (0.39%)

02/08/18
ADAM
02/08/18
UPGRADE
Target $48
ADAM
Buy
Canaccord sees 'significant upside' in AAR, upgrades to Buy
Canaccord Genuity analyst Ken Herbert upgraded AAR Corp. to Buy from Hold and raised his price target for the shares to $48 from $42. Amid continued strength in the commercial aerospace aftermarket, the analyst believes the company will benefit from positive inflections in earnings and free cash flow. He sees "significant upside" in the stock as new management can brings a "fresh perspective and focus to growth opportunities." The strength of AAR's balance sheet will provide potential capital deployment optionality, Herbert tells investors in a research note.
07/11/18
ADAM
07/11/18
NO CHANGE
Target $52
ADAM
Buy
AAR Corp. price target raised to $52 from $48 at Canaccord
Canaccord analyst Ken Herbert maintained a Buy rating on AAR Corp and raised his price target to $52 from $48, telling investors in a research note that the company's Q4 adjusted EPS of 52c was slightly ahead of his 50c estimate, but consistent with prior guidance, with revenues growing 5% from the same quarter last year. Herbert says management indicated that the INL/A contract ramp up is on track, and he continues to see a significant step-up in FY19 EPS and free cash flow, which should be positive for the stock.
02/08/18
ADAM
02/08/18
UPGRADE
ADAM
Buy
AAR Corp. upgraded to Buy from Hold at Canaccord
03/21/18
ADAM
03/21/18
NO CHANGE
Target $48
ADAM
Buy
AMR's move to exit COCO a 'positive,' says Canaccord
Canaccord analyst Ken Herbert maintained his Buy rating and $48 price target on AMR Corp following the company's Q3 results and news that it will pursue the sale of its COCO business, which he called a "positive." In a research note to investors, Herbert acknowledged that management "seemed to struggle" with outlining the financial impact of the COCO exit relative to fiscal 2019 guidance, and noted that "there is a lack of obvious buyers" for the unit. He continues to like AMR for its position in the commercial after market, and believes the company will deliver on FY19 guidance, EPS and free cash flow in particular.
BWXT BWX Technologies
$63.76

0.3 (0.47%)

05/24/18
05/24/18
DOWNGRADE
Target $70

Neutral
BWX Technologies downgraded to Neutral on valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded BWX Technologies to Neutral from Buy. Analyst Ronald Epstein said valuation reflects US Navy and medical radioisotopes growth and maintained a $70 price target on shares.
05/22/18
FBCO
05/22/18
NO CHANGE
Target $64
FBCO
Neutral
BWX Technologies price target lowered to $64 from $72 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for BWX Technologies to $64 from $72 as he downgrades his outlook for Defense hardware stocks to neutral from bullish. The analyst reiterates a Neutral rating on the shares.
06/18/18
JEFF
06/18/18
NO CHANGE
Target $21
JEFF
Buy
Lantheus position in moly more secure than stock suggests, says Jefferies
A presentation by new molybdenum-99 supplier SHINE Medical Technologies adds more support to Lantheus' (LNTH) position in the market being more secure than the current stock price reflects, Jefferies analyst Raj Denhoy tells investors in a research note. SHINE expects to bring production online in 2021, with Lantheus already contracted to use its molybdenum-99, the analyst adds. He believes the market is "vastly overestimating" the threat from new entrants and "vastly underappreciating" the company's "hold on this market." Denhoy sees little chance of BWX Technologies (BWXT) gaining significant traction given the manufacturing and regulatory challenges in bringing a generator to market. He keeps a Buy rating on Lantheus with a $21 price target.
05/24/18
BOFA
05/24/18
DOWNGRADE
BOFA
Neutral
BWX Technologies downgraded to Neutral from Buy at BofA/Merrill
CRZO Carrizo Oil & Gas
$23.30

-0.57 (-2.39%)

06/07/18
06/07/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Darden (DRI) upgraded to Buy from Hold at SunTrust with Jake Bartlett citing his view that its multiple will expand with modest comp sales outperformance beyond fiscal 2018, accelerating unit growth, resumed acquisitions and a higher dividend. 2. Wingstop (WING) upgraded to Outperform from Neutral at Wedbush with analyst Nick Setyan saying he believes drivers of same store sales growth and margin upside relative to current consensus 2018 and 2019 estimates exist. 3. LabCorp (LH) upgraded to Overweight from Sector Weight at KeyBanc with analyst Donald Hooker saying he sees LabCorp and Quest Diagnostics (DGX) benefiting over time from their recent contracts with United Healthcare (UNH) and Aetna (AET). 4. Carrizo Oil & Gas (CRZO) upgraded to Buy from Hold at Tudor Pickering. 5. Canadian Solar (CSIQ) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster saying risks from China's new solar policy appear priced in the shares at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/13/18
BMOC
06/13/18
NO CHANGE
Target $33
BMOC
Outperform
Carrizo Oil & Gas price target raised to $33 from $30 at BMO Capital
BMO Capital analyst Dan McSpirit raised his price target on Carrizo Oil to $33 and kept his Outperform rating. The analyst cites the company's relatively lower exposure to the "takeaway tension" in the Permian basin, saying that while the re-rating of the shares is already under way, more upside can be expected from Carrizo's favorable basin differential and its less flow-challenged Eagle Ford operations.
06/28/18
STFL
06/28/18
NO CHANGE
Target $34
STFL
Buy
Carrizo Oil & Gas price target lowered to $34 from $44 at Stifel
Stifel analyst Michael Scialla lowered his Net Asset Value, or NAV, for Carrizo Oil & Gas by 22% as he disaggregated the company's Delaware Basin position into three core operating areas and he also modestly lowered his Wolfcamp A/B type curve. Given the adjustments to his model, Scialla lowered his price target on Carrizo shares to $34 from $44. He keeps a Buy rating on the name, calling the company one of the few mid-cap companies he covers with material exposure to the Eagle Ford, where he believes oil prices could sustain a meaningful advantage over WTI and Midland prices for the next two years.
08/08/18
JRCO
08/08/18
UPGRADE
JRCO
Buy
Carrizo Oil & Gas upgraded to Buy from Accumulate at Johnson Rice
CVGI Commercial Vehicle Group
$9.99

0.01 (0.10%)

CW Curtiss-Wright
$134.12

-1 (-0.74%)

08/15/18
UBSW
08/15/18
INITIATION
Target $140
UBSW
Neutral
Curtiss-Wright initiated with a Neutral at UBS
UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Curtiss-Wright with a Neutral rating and $140 price target.
07/02/18
07/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. RPM (RPM) upgraded to Neutral from Underweight at JPMorgan with analyst Jeffrey Zekauskas saying he believes investors are now more willing to pay a higher multiple for RPM EBITDA because of new possibilities of cost reduction, changes in capital structure, or overall changes to the company given the involvement of activist Elliott Management. 2. Capital One (COF) upgraded to Outperform from Neutral at Credit Suisse with analyst Moshe Orenbuch citing improving credit quality, ahead of the industry. 3. Wells Fargo (WFC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Betsy Graseck stating that the bank's passing the 2018 CCAR stress test removes an overhang and indicates to her that the Fed is receptive of the changes Wells is making. 4. ZTE Corp. (ZTCOY) upgraded to Buy from Underperform at Jefferies with analyst Edison Lee saying Li Zixue becoming Chairman of the Board is an important step toward meeting the conditions of the company's settlement with the U.S. 5. Curtiss-Wright (CW) upgraded to Outperform from Market Perform at William Blair with analyst Nicholas Heymann saying the valuation is "compelling" following the recent correction in the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/02/18
WBLR
07/02/18
UPGRADE
WBLR
Outperform
William Blair upgrades Curtiss-Wright on 'compelling' valuation
William Blair analyst Nicholas Heymann upgraded Curtiss-Wright to Outperform from Market Perform saying the valuation is "compelling" following the recent correction in the shares. Further, the analyst finds it likely that Curtiss-Wright's next China Direct order will not be disrupted by ongoing trade tariffs with China. He also sees the prospect for better understanding of the company's underlying "continued strong double-digit earnings growth" excluding one-time costs from recent acquisitions. Heymann believes a fair valuation for Curtiss-Wright is 22 times his unchanged 2019 estimated earnings per share of $6.35.
08/21/18
RHCO
08/21/18
NO CHANGE
Target $41
RHCO
Buy
SunTrust raises price target on Aerojet Rocketdyne and Heico
SunTrust analyst Michael Ciarmoli raised his price target on Aerojet Rocketdyne (AJRD) to $41 from $36 and Heico (HEI) to $85 from $76 as part of his broader research note on the Aerospace & Defense sector. The analyst notes that select names will benefit from his expected "swift passage" of the FY19 defense spending bill that will yield accelerated bookings and growth in the second half of FY18. Ciarmoli also highlights buy-rated Curtis Wright (CW) and L3 Technologies (LLL) as his favorite long ideas.
FSS Federal Signal
$26.05

-0.1 (-0.38%)

08/08/18
KEYB
08/08/18
DOWNGRADE
KEYB
Sector Weight
Federal Signal downgraded to Sector Weight from Overweight at KeyBanc
02/20/18
SIDC
02/20/18
INITIATION
Target $21
SIDC
Neutral
Federal Signal initiated with a Neutral at Sidoti
Sidoti initiated Federal Signal with a Neutral and $21 price target.
GDP Goodrich Petroleum
$13.04

0.245 (1.92%)

10/18/17
10/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aaron's (AAN) initiated with a Neutral at Janney Capital. 2. Inovio (INO) initiated with an Outperform at RBC Capital. 3. Carrizo Oil & Gas (CRZO) reinstated with a Neutral at Goldman Sachs. 4. Goodrich Petroleum (GDP) assumed with a Buy at Seaport Global. 5. Krystal Biotech (KRYS) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/17
BARD
12/19/17
INITIATION
Target $15
BARD
Outperform
Goodrich Petroleum initiated with an Outperform at Baird
Baird analyst Joseph Allman initiated Goodrich Petroleum with an Outperform and $15 price target.
10/18/17
GHSC
10/18/17
INITIATION
Target $17
GHSC
Buy
Goodrich Petroleum assumed with a Buy at Seaport Global
Seaport Global analyst analyst Mike Kelly assumed coverage on Goodrich Petroleum with a Buy and $17 price target.
10/03/17
EROP
10/03/17
INITIATION
Target $16
EROP
Buy
Goodrich Petroleum initiated with a Buy at Euro Pacific
Euro Pacific initiated Goodrich Petroleum with a Buy and $16 price target.
HPR HighPoint Resources
$5.29

0.17 (3.32%)

04/26/18
JPMS
04/26/18
INITIATION
Target $10
JPMS
Overweight
HighPoint Resources initiated with an Overweight at JPMorgan
JPMorgan started HighPoint Resources with an Overweight rating and $10 price target.
04/26/18
JPMS
04/26/18
INITIATION
Target $10
JPMS
Overweight
JPMorgan initiates 'compelling and cheap' HighPoint with Overweight rating
JPMorgan analyst Gabriel Daoud initiated HighPoint Resources with an Overweight rating and $10 price target. The company stands out as a Denver-Julesburg Basin pure-play with scale, Daoud tells investors in a research note. The analyst sees a "compelling and cheap growth story." He says HighPoint represents an "interesting, oil-levered opportunity" outside the Permian that "warrants attention and could potentially thrive in the current environment."
04/26/18
04/26/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Omega Healthcare (OHI) initiated with a Market Perform at Raymond James. 2. HighPoint Resources (HPR) initiated with an Overweight at JPMorgan. 3. Veritone (VERI) initiated with a Buy at DA Davidson. 4. Pegasystems (PEGA) initiated with a Buy at DA Davidson. 5. Apollo Medical (AMEH) initiated with a Buy at Dougherty. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/18
LTCO
06/25/18
UPGRADE
Target $9
LTCO
Buy
HighPoint Resources upgraded to Buy from Neutral at Ladenburg
Ladenburg analyst Michael Schmitz upgraded HighPoint Resources to Buy from Neutral and raised his price target to $9 from $8, telling investors in a research note that following the recent acquisition of Hereford, he believes HighPoint is well-positioned to generate significant near-term production growth and generate positive free cash flow by the second half of 2019.
HSC Harsco
$27.30

-0.3 (-1.09%)

05/02/18
LSCM
05/02/18
NO CHANGE
Target $30
LSCM
Buy
Harsco 'excellent' Q1 increases confidence in growth, says Lake Street
Lake Street analyst Robert Brown says Harsco's Q1 results were "outstanding" and he believes shares have meaningful further upside as Harsco shifts to a growth mode and continues to realize operating margin expansion. Also, the announcement of a $75M repurchase authorization bolsters confidence in the sustainability of free cash flow and should be a positive catalyst for shares, he contends. Brown reiterates a Buy rating and $30 price target on the shares.
05/30/18
LSCM
05/30/18
NO CHANGE
Target $31
LSCM
Buy
Harsco target raised to $31 on deal accretion at Lake Street
Lake Street analyst Robert Brown raided his price target for Harsco to $31 from $30 citing accretion from the acquisition of Altek Group. Harsco has "now turned to offense with an accretive acquisition that expands into the aluminum vertical and adds additional growth paths in its waste-to-value strategy," Brown tells investors in a research note. He now has increased confidence in the company reaching its long-term goals of $2B in revenue and $400M in EBITDA. The analyst keeps a Buy rating on the shares.
08/03/18
LSCM
08/03/18
NO CHANGE
Target $31
LSCM
Buy
Harsco quarter the strongest in at least five years, says Lake Street
Lake Street analyst Robert Brown views Harsco's Q2 results and "excellent" and reiterates a Buy rating on the shares with a $31 price target. The Street is underappreciating the company's margin expansion opportunity and free cash flow potential, Brown tells investors in a post-earnings research note. He believes the Harsco's Q2 results were the strongest in at least five year as the company is seeing the results from its turnaround efforts and benefiting from a recovery in the industrial and rail end markets. The analyst now has increased confidence that Harsco can reach 13% operating margin at its long-term goal of $2B in revenue.
02/23/18
LSCM
02/23/18
NO CHANGE
Target $30
LSCM
Buy
Harsco shares have 'meaningful further upside,' says Lake Street
Lake Street analyst Robert Brown raised his price target for Harsco to $30 from $26 citing improving fundamentals following the company's Q4 results. The shares have "meaningful further upside" as Harsco shifts to a growth mode and continues to realize operating margin expansion, Brown tells investors in a post-earnings research note. He keeps a Buy rating on the name.
IEA Infrastructure and Energy Alternatives
$10.08

-0.08 (-0.79%)

KTOS Kratos Defense
$13.26

0.2 (1.53%)

07/31/18
ADAM
07/31/18
NO CHANGE
Target $15
ADAM
Buy
Canaccord cautious on Kratos Q2 ahead of second half inflection
Canaccord analyst Ken Herbert said he is cautious on Kratos Defense ahead of Q2 results, but he sees tactical opportunities coming into view that brings it to an inflection in the second half of the year. The analyst said his assumptions in the Government Solutions segment is more conservative, but he believes the Unmanned segment could grow 35% organically in the quarter. He also believes progress on the tactical drone programs is progressing at an accelerated pace. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
06/05/18
ADAM
06/05/18
NO CHANGE
Target $15
ADAM
Buy
Kratos Defense visibility reinforces revenue conviction at Canaccord
Canaccord analyst Ken Herbert met with Kratos Defense management and came away with reinforced conviction about the company's revenue upside from both the legacy target drone business and the emerging tactical drone opportunity. He also sees the company taking steps on improving margins and execution upside. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
04/18/18
ADAM
04/18/18
NO CHANGE
Target $15
ADAM
Buy
Gremlins contract to Dynetics a positive for Kratos, says Canaccord
Canaccord Genuity analyst Ken Herbert says DARPA awarding a $32M contract to Dynetics for the Phase III development of the Gremlins program is a net positive for Kratos Defense & Security Solutions. Under the contract, Kratos will be the sole supplier of the drones, which will likely account for 30%-40% of the contract value, Herbert tells investors in a research note. The analyst sees a $10M in contribution for Kratos in 2018-2019, but believes the contract points to both the strong positioning of the company in the unmanned market and potential upside from its tactical opportunity. Herbert points out that the program goal is to acquire aircraft at $700,000 each in lots of 1,000, indicating upside of well over $100M for Kratos. The stock and estimates does not reflect much upside from the tactical drone opportunities, Herbert writes. He keeps a Buy rating on Kratos Defense with a $15 price target. The stock in early trading is up 5% to $11.55.
05/11/18
ADAM
05/11/18
NO CHANGE
Target $15
ADAM
Buy
Kratos Defense results support full-year optimism, says Canaccord
Canaccord analyst Ken Herbert said the Q1 results from Kratos Defense support higher confidence in the execution capabilities as well as top-line upside. He noted the highlight in the quarter was the strong performance of the KUSD segment and the company maintained its full year guidance. Herbert reiterated his Buy rating and $15 price target on Kratos Defense shares.
LECO Lincoln Electric
$93.57

-0.34 (-0.36%)

03/12/18
KEYB
03/12/18
UPGRADE
Target $110
KEYB
Overweight
Lincoln Electric upgraded to Overweight from Sector Weight at KeyBanc
KeyBanc analyst Steve Barger upgraded Lincoln Electric to Overweight with a $110 price target after hosting meetings with management. An industrial improving cycle, benefits from the Liquide integration, and increased earnings and cash flow from Lincoln's "high-quality, high-return franchise" creates an attractive investment opportunity, Berger tells investors in a research note.
01/16/18
STFL
01/16/18
UPGRADE
STFL
Buy
Lincoln Electric upgraded to Buy from Hold at Stifel
01/16/18
01/16/18
UPGRADE
Target $116

Buy
Lincoln Electric upgraded to Buy on 'unappreciated' tax cut benefits at Stifel
As previously reported, Stifel analyst Nathan Jones upgraded Lincoln Electric to Buy from Hold, as he believes Lincoln will see about a 15% boost to EPS and free cash flow from recent tax cuts though the stock price "appears to have ignored" this potential boost in recent weeks as the Tax Cuts and Jobs Act got passed. Jones raised his price target on Lincoln Electric shares to $116 from $97 to account for his increased estimates.
04/24/18
WLSD
04/24/18
UPGRADE
WLSD
Gradually Accumulate
Lincoln Electric upgraded to Gradually Accumulate from Hold at Wellington Shields
MNTX Manitex
$10.49

-0.15 (-1.41%)

02/08/18
ROTH
02/08/18
UPGRADE
ROTH
Buy
Manitex upgraded to Buy from Neutral at Roth Capital
11/07/17
ROTH
11/07/17
DOWNGRADE
Target $10
ROTH
Neutral
Manitex downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Matt Koranda downgraded Manitex to Neutral from Buy, with a $10 price target, as he awaits restatement of 2016 and year to date 2017 financials caused by a change in revenue treatment of certain transactions initiated in 2016. While he believes Manitex's business remains fundamentally sound with end markets rebounding from a deep cyclical trough, Koranda awaits complete restatements to provide a firmer basis for his investment opinion.
02/08/18
02/08/18
UPGRADE
Target $11

Buy
Manitex upgraded to Buy at Roth Capital
As previously reported, Roth Capital analyst Matt Koranda upgraded Manitex to Buy from Neutral after the company released delayed Q3 results and preannounced headline figures for Q4 ahead of consensus. Strong bookings from Q4 and January 18 also give him confidence that demand is durable and provide nice visibility into his first half of 2018 forecast. The analyst believes most of the overhang on shares has been removed with the auditor investigation now complete and restatements forthcoming. He also raised his price target on the shares to $11 from $10.
MRC MRC Global
$20.22

0.36 (1.81%)

07/31/18
NRCS
07/31/18
INITIATION
Target $26
NRCS
Buy
MRC Global initiated with a Buy at Northcoast
Northcoast analyst Ryan Cieslak initiated MRC Global with a Buy and $26 price target.
09/12/17
JPMS
09/12/17
NO CHANGE
JPMS
JPMorgan's fall playbook includes downgrades of Precision, Tetra
JPMorgan analyst Sean Meakim laid out his Fall 2017 playbook for the Oil Services & Equipment space and downgraded both Precision Drilling (PDS) and Tetra Technologies (TTM) to Neutral from Overweight. The analyst removed his price targets for both names. Both stocks, despite underperforming year-to-date, have few upside catalysts, Meakim tells investors in a research note. He notes Precision is now the most levered land driller in his coverage universe and that an "M&A bailout of the whole company" is unlikely for Tetra. Meakim's top picks in the sector are TechnipFMC (FTI) and Halliburton (HAL) among large caps and Core Laboratories (CLB), MRC Global (MRC) and ProPetro Holding (PUMP) among small- and mid-caps.
OII Oceaneering
$28.10

-0.21 (-0.74%)

04/30/18
RBCM
04/30/18
NO CHANGE
Target $26
RBCM
Outperform
Oceaneering price target raised to $26 from $22 at RBC Capital
RBC Capital analyst Kurt Hallead raised his price target on Oceaneering to $26, saying the company will be better positioned to maximize its opportunity in ROVs and Subsea products amid a shift in gears for the offshore spending cycle. The analyst is positive on the company's efforts to leverage its robotics technology beyond the traditional energy markets, even as the increased offshore activity and contract awards will likely lead to above-parity book-to-bill. Hallead keeps his Outperform rating on Oceaneering.
05/14/18
GSCO
05/14/18
UPGRADE
Target $29
GSCO
Buy
Oceaneering upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Waqar Syed upgraded Oceaneering to Buy from Neutral and raised its price target to $29 from $22. With Brent oil around the mid-$70/bbl range, Syed believes we are in the early stages of an offshore cycle. He notes Oceaneering's break-even prices for offshore projects are down 40%-60% from 2016 levels, and offshore project FIDs, deepwater IMR work, and drilling activity are poised to inflect higher, while valuation is near historical lows.
07/30/18
GABE
07/30/18
UPGRADE
GABE
Buy
Oceaneering upgraded to Buy from Hold at Gabelli
Gabelli analyst Simon Wong upgraded Oceaneering to Buy with a $37 private market value following the Q2 beat citing valuation and an improving offshore drilling environment.
05/24/18
WELS
05/24/18
UPGRADE
Target $24
WELS
Market Perform
Oceaneering upgraded to Market Perform from Underperform at Wells Fargo
Wells Fargo analyst Judson Bailey upgraded Oceaneering to Market Perform from Underperform as he no longer sees downside risk to estimates based on a better macro outlook. The analyst also raised his price target on the shares to $24 from $17.
PDCE PDC Energy
$55.01

1.24 (2.31%)

08/07/18
MACQ
08/07/18
DOWNGRADE
MACQ
Neutral
PDC Energy downgraded to Neutral from Outperform at Macquarie
08/03/18
GSCO
08/03/18
DOWNGRADE
Target $21
GSCO
Neutral
WPX Energy downgraded to Neutral from Conviction Buy at Goldman Sachs
Goldman Sachs analyst John Nelson downgraded WPX Energy (WPX) to Neutral and removed the shares from his firm's Conviction List. The analyst believes the company's secular growth outlook remains intact and cites valuation for the downgrade. WPX's valuation is less differentiated at current share levels, and investors should rotate into Diamondback Energy (FANG) and PDC Energy (PDCE), which offer greater upside potential, Nelson tells investors in a research note. The analyst has a $21 price target for WPX shares.
08/14/18
FBCO
08/14/18
NO CHANGE
Target $62
FBCO
Neutral
PDC Energy price target lowered to $62 from $71 at Credit Suisse
Credit Suisse analyst Betty Jiang lowered her price target for PDC Energy to $62 from $71 to reflect Colorado regulatory risk. The analyst reiterates a Neutral rating on the shares.
08/07/18
MACQ
08/07/18
DOWNGRADE
MACQ
Neutral
PDC Energy downgraded to Neutral at Macquarie
Macquarie analyst Paul Grigel downgraded PDC Energy to Neutral and reduced its price target to $65 from $68 given increased risk from Colorado Initiative 97. The initiative establishes a minimum setback of oil and gas wells to 2,500 feet from the current 500 feet for homes and 1,000 feet for schools. Grigel said the initiative faces an uphill battle, but recent changes in Colorado's population, high profile events, increased Democratic party support, and a wild card national election creates more uncertainty.
REGI Renewable Energy
$25.75

-0.7 (-2.65%)

05/17/18
ROTH
05/17/18
NO CHANGE
Target $21
ROTH
Buy
Renewable Energy price target raised to $21 from $17 at Roth Capital
Roth Capital analyst Craig Irwin raised his price target on Renewable Energy to $21 from $17 after meeting with company management, stating that he came away with the view that market trends support improving profitability into the fourth quarter of 2018 and adding that he sees its next operational catalyst coming from the REG-Geismar expansion. Irwin keeps a Buy rating on Renewable Energy shares.
06/26/18
ADAM
06/26/18
NO CHANGE
Target $20
ADAM
Buy
Renewable Energy price target raised to $20 from $16 at Canaccord
Canaccord analyst Chip Moore raised his price target on Renewable Energy to $20 from $16 as he continues to find the current risk/reward compelling. He said the combination of a more favorable biodiesel backdrop, an enhanced platform, and solid management execution are supportive of a more highly valued enterprise. Moore reiterated his Buy rating on Renewable Energy shares.
SLB Schlumberger
$64.07

-0.77 (-1.19%)

06/29/18
WELS
06/29/18
UPGRADE
Target $8
WELS
Outperform
Nabors Industries upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Judson Bailey upgraded Nabors Industries (NBR) to Outperform with an unchanged price target of $8. The analyst sees further downside risk to pressure pumping and proppant pricing and favors defensive "value" stocks that have "somewhat limited" downside earnings risk. His top four picks remain TechnipFMC (FTI), Baker Hughes (BHGE), Weatherford (WFT) and Schlumberger (SLB).
06/19/18
BOFA
06/19/18
NO CHANGE
BOFA
CVS Health added to US 1 List, Schlumberger removed at BofA/Merrill
06/13/18
SBSH
06/13/18
NO CHANGE
Target $79
SBSH
Buy
Schlumberger target lowered to $79 on Q2 guide down at Citi
Citi analyst Scott Gruber lowered his price target for Schlumberger to $79 from $84 after the company yesterday guided Q2 earnings growth to 10%-15% growth or around 42c, compared to the consensus of 46c and his estimate of 45c. Sales should approach consensus, but profit margins will be weighed down by start-up costs and delays on integrated drilling contracts, and less activity in Russia, Gruber tells investors in a research note. The analyst keeps a Buy rating on the shares. He trimmed his Q3 earnings per share to 55c and believes the consensus forecast of 55c is achievable.
06/01/18
MSCO
06/01/18
NO CHANGE
Target $31
MSCO
Overweight
Golar LNG 26% selloff yesterday overdone, says Morgan Stanley
Morgan Stanley analyst Fotis Giannakoulis views the 26% pullback in shares of Golar LNG (GLNG) as overdone. The dissolution of the OneLNG joint venture with Schlumberger (SLB) is raising more doubts on Fortuna and further upstream expansion, Giannakoulis tells investors in a research note. Golar's FLNG thesis remains intact as the Hilli Episeyo is already producing cargoes in Cameroon, while the recent agreement with BP (BP) for the Torture project in Mauritania/Senagal is another confirmation of the value proposition, the analyst contends. He lowered his price target for Golar LNG to $31 from $36 and keeps an Overweight rating on the shares.
SLCA U.S. Silica
$22.34

-0.1 (-0.45%)

07/12/18
07/12/18
DOWNGRADE

Equal Weight
U.S. Silica cut to Equal Weight in Permain ratings shake-up at Morgan Stanley
As previously reported, Morgan Stanley analyst Connor Lynagh downgraded U.S. Silica to Equal Weight from Overweight as he reduced his 2019 Hz rig count forecast by about 6%, to 908 rigs, on average. Given his view that Permian constraints will "dominate the narrative" through the Q2 earnings season, and his belief that the Permian's regional weakness has potential to transmit to other basins, Lynagh recommends decreasing completions exposure and increasing land drilling exposure.
08/28/18
FBCO
08/28/18
NO CHANGE
Target $29
FBCO
Outperform
U.S. Silica price target lowered to $29 from $38 at Credit Suisse
Credit Suisse analyst James Wicklund lowered his price target for U.S. Silica to $29 from $38 as the confluence of increasing industry capacity in the face of a temporary slowdown in Permian activity will have an impact on industry pricing. The analyst reiterates an Outperform rating on the shares.
08/20/18
JRCO
08/20/18
DOWNGRADE
JRCO
Accumulate
U.S. Silica downgraded to Accumulate from Buy at Johnson Rice
Johnson Rice analyst Martin Malloy U.S. Silica to Accumulate from Buy and cut its price target to $30 from $38. Malloy expects frac sand prices will likely continue to move down as additional in-basin mine capacity continues to be added over the next several quarters in the Permian, Eagleford, and Mid-Con basins.
07/24/18
OTRG
07/24/18
NO CHANGE
OTRG
Frac Sand Market downgraded to Negative from Mixed at OTR Global
OTR Global downgraded the Frac Sand Market to Negative following checks that suggest expanding capacity in several basins and share gains at regional/in-basin sands.
TREX Trex Company
$83.28

1.04 (1.26%)

08/10/18
SIDC
08/10/18
DOWNGRADE
SIDC
Neutral
Trex Company downgraded to Neutral from Buy at Sidoti
05/08/18
SIDC
05/08/18
UPGRADE
SIDC
Buy
Trex Company upgraded to Buy from Neutral at Sidoti
08/01/18
RHCO
08/01/18
NO CHANGE
Target $73
RHCO
Hold
Trex Company price target raised to $73 from $52.50 at SunTrust
SunTrust analyst Keith Hughes raised his price target on Trex to $73 after its Q2 earnings beat, saying the company continues to generate organic growth and "excellent margin execution" despite the higher costs associated with marketing expenses and transportation. The analyst also keeps his Hold rating on Trex, noting that the stock is trading at more than double the average valuation of its peer group at about 28-times enterprise value to FY19 earnings estimates.
07/31/18
RILY
07/31/18
NO CHANGE
Target $75
RILY
Buy
Trex Company price target raised to $75 from $64.50 at B. Riley FBR
B. Riley FBR analyst Alex Rygiel raised his price target for Trex Company to $75 saying yesterday's Q2 represents another solid quarter. The analyst upped his estimates and reiterates a Buy rating on the shares.
WERN Werner
$36.70

-0.45 (-1.21%)

07/11/18
JPMS
07/11/18
DOWNGRADE
Target $35
JPMS
Underweight
Werner downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Brian Ossenbeck downgraded Werner Enterprises (WERN) to Underweight and lowered his price target for the shares to $35 from $42. Consensus estimates look too high for 2019 unless the company can boost rates and productivity while growing the fleet, a feat accomplished only once in fifteen years, Ossenbeck tells investors in a research note. The analyst prefers of U.S. Xpress Enterprises (USX) to Werner, which he says offers a 50% discount with similar exposure and greater operating leverage.
07/24/18
07/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mosaic (MOS) double upgraded to Buy from Underperform at BofA/Merrill with analyst Steve Byrne saying he believes 2018 will mark a bottom in global phosphate utilization rates and now believes there is more upside risk to consensus estimates as the cycle improves. 2. Live Nation (LYV) upgraded to Buy from Neutral at BTIG with analyst Brandon Ross saying he is now more convinced that the company will outperform expectations amid inflecting growth rate with an added possibility of M&A. 3. Infinera (INFN) upgraded to Outperform from Market Perform at Northland with analyst Tim Savageaux saying the calculus of his March downgrade changes with the acquisition of Coriant, giving the company a double-digit market share in 100G+ optical systems. 4. Baker Hughes (BHGE) upgraded to Buy from Hold at SunTrust with analyst Ken Sill saying the EPS miss was due to higher interest expense and taxes, as well as an asset charge that is "hopefully non-recurring." 5. Werner (WERN) upgraded to Neutral from Underperform at BofA/Merrill with analyst Ken Hoexter saying Q2 freight demand in One way Truckload was much stronger than normal and revenue per load mile was up 13.3% year-over-year, the strongest level in more than 20 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/18
BOFA
07/24/18
UPGRADE
BOFA
Neutral
Werner upgraded to Neutral from Underperform at BofA/Merrill
07/24/18
07/24/18
UPGRADE
Target $44

Neutral
Werner upgraded to Neutral on improved pricing at BofA/Merrill
As previously reported, BofA/Merrill upgraded Werner to Neutral from Underperform and increased its price target to $44 from $41 following the Q2 beat. Analyst Ken Hoexter said Q2 freight demand in One way Truckload was much stronger than normal and revenue per load mile was up 13.3% year-over-year, the strongest level in more than 20 years. The analyst expects Werner's multiple to move up towards the historic range but for believes the market views earnings as close to peak levels.
WRD WildHorse Resource
$20.82

0.04 (0.19%)

08/08/18
RHCO
08/08/18
UPGRADE
RHCO
Buy
WildHorse Resource upgraded to Buy from Hold at SunTrust
07/19/18
RHCO
07/19/18
INITIATION
Target $26
RHCO
Hold
WildHorse Resource initiated with a Hold at SunTrust
SunTrust analyst Welles Fitzpatrick initiated WildHorse Resource with a Hold rating and a price target of $26, saying the company is a "pure play" for the "highly productive and delineated" NE Eagle Ford basin. The analyst is also positive on WildHorse Resource's access to Gulf Coast crude markets and its "consolidated position that allows the company to leverage scale". Despite the backdrop of strong oil pricing and significant differential realizations, Fitzpatrick keeps his Hold rating on WildHorse Resource, stating that its valuation is in-line with fundamentals.
08/09/18
08/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ormat Technologies (ORA) upgraded to Overweight from Neutral at JPMorgan by analyst Paul Coster. The company reported mixed Q2 results and guidance owing to disruption at the Puna plant in Hawaii, but Coster believes that when excluding Puna, Ormat's execution "remains solid" and the company's long-term growth prospects "remain undimmed." 2. Wright Medical (WMGI) upgraded to Buy from Neutral at BofA/Merrill by analyst Travis Steed, who cited increased confidence in 2H 2018 and 2019 double digit growth and upside to Street estimates. Steed said growth in the core lower extremities business returned to market rates for the first time since Q1 2016 and believes it can accelerate further from new products and productivity ramps. 3. WildHorse Resource (WRD) upgraded to Buy from Hold at SunTrust by analyst Welles Fitzpatrick, who noted that the 13% decline in the stock price "makes little sense" from differentials or CapEx point of view, adding that the move in pricing does not warrant the large decline. Fitzpatrick views WildHorse Resource as a "simple, single-basin story, with distinct, quantifiable advantages such as premium oil pricing given its gulf coast access, ability to realized material savings with an in-field sand mine, and optionality to expand its midstream system." 4. ITG (ITG) upgraded to Overweight from Neutral at JPMorgan by analyst Kenneth Worthington, saying that the company's fundamentals are improving as it gains "traction on a number of fronts" that have and will continue to drive higher earnings power over time, particularly outside the U.S. 5. Comstock Resources (CRK) upgraded to Buy from Neutral at Ladenburg by analyst Michael Schmitz, who said the recent pullback in shares provides an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/09/18
RHCO
08/09/18
UPGRADE
Target $25
RHCO
Buy
WildHorse Resource upgraded to Buy at SunTrust on valuation
As reported earlier, SunTrust analyst Welles Fitzpatrick upgraded WildHorse Resource to Buy from Hold but lowered his price target to $25 from $26 after its Q2 results. The analyst notes that the 13% decline in the stock price "makes little sense" from differentials or CapEx point of view, adding that the move in pricing does not warrant the large decline. Fitzpatrick views WildHorse Resource as a "simple, single-basin story, with distinct, quantifiable advantages such as premium oil pricing given its gulf coast access, ability to realized material savings with an in-field sand mine, and optionality to expand its midstream system".

TODAY'S FREE FLY STORIES

WK

Workiva

$37.20

0.65 (1.78%)

05:08
09/25/18
09/25
05:08
09/25/18
05:08
Upgrade
Workiva rating change  »

Workiva upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CY

Cypress Semiconductor

$15.52

-0.45 (-2.82%)

05:07
09/25/18
09/25
05:07
09/25/18
05:07
Downgrade
Cypress Semiconductor rating change  »

Cypress Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBTYA

Liberty Global

$28.37

-0.87 (-2.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Liberty Global management to meet with Wolfe Research »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

TRU

TransUnion

$73.68

-0.62 (-0.83%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TransUnion management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

NNBR

NN, Inc.

$15.65

-0.05 (-0.32%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
NN, Inc. to host two day investor day »

Two day investor day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 06

    Nov

CLAR

Clarus Corporation

$10.45

-0.3 (-2.79%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Clarus Corporation management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AMSC

AMSC

$6.33

-0.265 (-4.02%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AMSC management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

TSLX

TPG Specialty Lending

$20.56

-0.15 (-0.72%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
TPG Specialty Lending management to meet with JMP Securities »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

THR

Thermon Group

$25.98

-0.14 (-0.54%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Thermon Group management to meet with William Blair »

Group luncheon with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

04:55
09/25/18
09/25
04:55
09/25/18
04:55
General news
Richmond Fed Manufacturing Index Level to be reported at 10:00 »

September Richmond Fed…

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
AdvaMed to hold a conference »

MedTech Conference will…

IMPV

Imperva

$46.70

1.05 (2.30%)

, FIVN

Five9

$43.51

0.3 (0.69%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Microsoft to hold a conferenc e »

Microsoft Ignite will be…

IMPV

Imperva

$46.70

1.05 (2.30%)

FIVN

Five9

$43.51

0.3 (0.69%)

CDAY

Ceridian

$42.29

0.225 (0.53%)

MSFT

Microsoft

$114.72

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

TEN

Tenneco

$44.59

-0.9 (-1.98%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Tenneco management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Oct

SWCH

Switch

$10.85

-0.21 (-1.90%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SRNE

Sorrento Therapeutics

$4.23

-0.075 (-1.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Sorrento Therapeutics management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$78.75

2.44 (3.20%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Exact Sciences management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

KRYS

Krystal Biotech

$17.68

0.8 (4.74%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Krystal Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

GMED

Globus Medical

$54.09

-0.04 (-0.07%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Globus Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

CZWI

Citizens Community Bancorp

$14.09

-0.04 (-0.28%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABT

Abbott

$71.43

2.38 (3.45%)

, ABMD

Abiomed

$419.53

34.84 (9.06%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Cardiovascular Research Foundation »

TCT 2018 will be held in…

ABT

Abbott

$71.43

2.38 (3.45%)

ABMD

Abiomed

$419.53

34.84 (9.06%)

AMGN

Amgen

$207.30

2.25 (1.10%)

AZN

AstraZeneca

$37.84

0.155 (0.41%)

BSX

Boston Scientific

$38.39

0.63 (1.67%)

CAE

CAE

$20.10

-0.345 (-1.69%)

CAJ

Canon

$31.52

-0.165 (-0.52%)

CSII

Cardiovascular Systems

$37.16

0.42 (1.14%)

EW

Edwards Lifesciences

$165.52

11.81 (7.68%)

HCA

HCA Healthcare

$134.31

0.95 (0.71%)

ICLR

Icon

$149.62

-0.54 (-0.36%)

LIVN

LivaNova

$124.79

2.46 (2.01%)

MDT

Medtronic

$98.85

1 (1.02%)

PHG

Philips

$45.68

-0.18 (-0.39%)

REGN

Regeneron

$390.39

-0.16 (-0.04%)

SNY

Sanofi

$43.40

-0.21 (-0.48%)

SIEGY

Siemens

$0.00

(0.00%)

TFX

Teleflex

$268.91

-0.84 (-0.31%)

VBLT

VBL Therapeutics

$1.58

-0.025 (-1.56%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 29

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 09

    Oct

  • 11

    Oct

  • 17

    Oct

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 08

    Nov

  • 09

    Nov

  • 27

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

LLESY

Lendlease Group

$0.00

(0.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Lendlease Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

NGG

National Grid

$51.46

-0.62 (-1.19%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
National Grid management to meet with JPMorgan »

Meetings to be held New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

YGYI

Youngevity

$5.80

0.8 (16.00%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Youngevity management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

ANTM

Anthem

$273.26

0.5 (0.18%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Anthem management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

WTW

Weight Watchers

$72.88

3.11 (4.46%)

04:55
09/25/18
09/25
04:55
09/25/18
04:55
Conference/Events
Weight Watchers management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.